Theratechnologies

YTD

ALL

Why Robinhood?

You can watch THTX and buy or sell other stocks, ETFs, and their options commission-free!

About THTX

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.

CEO

Paul Lévesque

CEOPaul Lévesque

Employees

105

Employees105

Headquarters

Montréal, Québec

HeadquartersMontréal, Québec

Founded

1993

Founded1993

Employees

105

Employees105

THTX Key Statistics

Market cap

155.87M

Market cap155.87M

Price-Earnings ratio

-17.18

Price-Earnings ratio-17.18

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$3.40

52 Week high$3.40

52 Week low

$1.12

52 Week low$1.12

People also own

Based on the portfolios of people who own THTX. This list is generated using Robinhood data, and it’s not a recommendation.